Grapefruit USA, Inc.

Equities

GPFT

US3885981049

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 12:57:48 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0014 ^USD	0.00%		+16.67%	+7.69%

2022	Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
2022	Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc	CI

Grapefruit Usa, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021

May 24, 2021 at 05:21 pm EDT

Grapefruit USA, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 350,815 compared to USD 393,559 a year ago. Operating loss was USD 477,628 compared to USD 363,987 a year ago. Net loss was USD 1.416 million compared to USD 2.772 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.

Latest news about Grapefruit USA, Inc.

Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-18	CI
Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc	22-09-29	CI
Grapefruit USA, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-22	CI
Grapefruit USA, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-20	CI
California Department of Cannabis Control Renews Grapefruit USA's California Cannabis Distributor License by May 13, 2023	22-04-25	CI
Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass Time Release THC+CBD Delivery Cream	22-04-19	CI
Grapefruit USA, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15	CI
Grapefruit USA, Inc. Auditor Raises 'Going Concern' Doubt	22-04-14	CI
Grapefruit’S Summit Boys Brand Goes Mobile on Blitzdirect.com	22-04-04	CI
Grapefruit USA, Inc. signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc.	22-03-27	CI
Grapefruit USA, Inc. Updates on Hourglass Health Canada NNCP Submission	22-03-03	CI
Grapefruit Usa, Inc. Announces CEO Bradley J. Yourist Has Been Elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’S Property Owners Association Board of Directors	22-02-23	CI
Grapefruit USA Announce Official Launch of Patented Time-Release, Hemp-Based CBD Topical Cream with Boosted Bioavailability, Made Possible by Its Proprietary Hourglass? Technology	21-12-06	CI
Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Grapefruit USA Announces Expanded Agreement with Canadian Firms Medz Cannabis and 6PAK Solutions to Shepherd Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream Through Health Canada’s Regulatory Process	21-10-13	CI
Grapefruit USA, Inc. acquired 51% stake in Summit Boys, Inc. from one of founders for $0.2 million.	21-09-14	CI
Grapefruit USA, Inc. Issues Further Update Concerning Formation of Joint Venture with Canadian Partner to Distribute Hourglass Products in Canada, Possible Acquisition	21-09-07	CI
Grapefruit Usa, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-20	CI
One Plant’s California Cannabis Dispensaries to Carry Grapefruit’s Patented Hourglass THC/CBD Delivery Cream	21-08-05	CI
Captor Capital’s California Retail Cannabis Dispensaries to Carry Grapefruit’s Patented Hourglass THC/CBD Delivery Cream	21-07-06	CI
Grapefruit USA, Inc. Announces New Strategic Alliance with 6Pak Solutions Canada to Shepherd Grapefruit’s Patented Hourglass Time Release Thc+CBD Delivery Cream	21-06-28	CI
Grapefruit Usa, Inc. Expands its Hemp Based CBD Products with a New USDA Certified Organic CBD Pet Tincture	21-06-14	CI
Grapefruit USA, Inc. Reports Revenue Result for the Quarter Ended March 31, 2021	21-05-25	CI
Grapefruit Usa, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-24	CI
Grapefruit USA, Inc. Launches New Affiliate Program in Conjunction with New E-Commerce Store	21-05-10	CI

Chart Grapefruit USA, Inc.

Duration

Period

More charts

Company Profile

Grapefruit USA, Inc. is a fully licensed cannabiotech company. The Company manufactures its product line and distribute it, along with other cannabis products, to all licensed cannabis product businesses. It owns an ethanol extraction facility in the City of Desert Hot Springs, California. It owns and operates a Type 6 Ethanol Extraction Plant which removes the essential cannabis compounds, such as THC Distillate, that the Company, and others use, to produce cannabis products. Grapefruit manufactures its Hourglass Time Release THC+CBD-Infused Topical Cream at its Coachillin' facility. Hourglass is the full spectrum THC+ Cannabinoid Topical delivery Cream that provides its users with a full body, synergistic entourage. Its Topical Cream is designed to deliver the full effects of THC combined with a range of cannabinoids for a user's overall health, wellness, and well-being. In addition, its extraction lab produces distillate or Honey Oil from cannabis trim sourced by Grapefruit.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
GRAPEFRUIT USA, INC.	+7.69%	1.55M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution